Thuenthkin Anbelos

Health Insurance 2.0

noreply@blogger.com (Thuenthkin Anbelos) — Wed, 27 Jan 2010 16:35:00 +0000

Health Insurance 2.0 -- Social Media Resurrects Old-School Values

HCC Medical Insurance Services, LLC - Online leader striving to provide world-class customer service via Social Media.

Indianapolis, IN, December 19, 2009 -- There was a time when customers had to make personal visits to receive assistance. To make these tasks more convenient and cost-effective, companies developed automated systems to support customers 24/7. However, as popular radio host Clark Howard frequently comments, the result has been "customer no service."

With this development, companies are forgetting that customers are the critical element to business success.

HCC Medical Insurance Services, LLC (HCCMIS) was recently featured in the article, "Old-line Companies Turn to Social Media for Marketing," as a leading company in the insurance industry that develops strong business and customer relationships through social media.

Muhammad Yasin, HCCMIS Client Relations Manager explains, "Our goal is to enhance the insurance experience with a deeply personal and timely communication style people have become accustomed to through social media."

For companies focusing on Health Insurance 2.0, this means proactively monitoring consumer sentiments and responding in a way that makes customers feel secure. Yasin states, "With the advent of internet and mobile technology, the world is shrinking rapidly. Resurrecting community-style relationships as people travel through their life adventure is something we are passionate about."

Recently, HCCMIS found a dissatisfied customer by monitoring the internet. They discovered that a medical center billed the customer twice. HCCMIS contacted the facility, arranged for customer reimbursement, and followed up with the customer via Twitter.

This is only one example of many where HCCMIS is striving to provide world-class customer service via Social Media.

About HCCMIS
HCC Medical Insurance Services is a wholly owned subsidiary of HCC Insurance Holdings, Inc. (NYSE: HCC), a leading international specialty insurance group with offices across the United States and in the United Kingdom, Spain and Ireland. HCC has assets of $9.0 billion, shareholders' equity of $3.0 billion and is rated AA (Very Strong) by Standard & Poor's and AA (Very Strong) by Fitch Ratings. In addition, HCC's major domestic insurance companies are rated A+ (Superior) by A.M. Best Company.

Contact Information
HCC Medical Insurance Services, LLC
Bryant Tutterow
317-221-8037
btutterow@hccmis.com
www.hccmis.com

Ohio Scientists Determine Asbestos Causes Cancer

noreply@blogger.com (Thuenthkin Anbelos) — Sat, 16 Jan 2010 05:46:00 +0000

LegalView Reports Development of a Breakthrough Study Explaining How Asbestos Causes Mesothelioma Cancer

LegalView recently reported of a study by scientists at Ohio State University who are attempting to determine the molecular details of how asbestos fibers bind to human cancer cells. The scientists hope that with the study, they will eventually be able to produce more adequate mesothelioma treatments.

Denver, CO, January 01 -- LegalView.com, the most comprehensive legal resource available on the Internet, recently informed its mesothelioma information blog readers of the development of a breakthrough study by Ohio State University researchers as to how asbestos fibers bind to human cells to cause the deadly condition known as mesothelioma. The scientists will be using a method known as atomic force microscopy "to observe how a single asbestos fiber binds with a specific receptor protein on cell surfaces," according to a Dec. 22 Science Daily news article. Although the study is years away from being complete, scientists hope that one day they may be able to offer a better understanding of the development of the condition, which will result in a more comprehensive knowledge of the disease and more adequate treatments.

Mesothelioma cancer is a condition that occurs in individuals who have inhaled asbestos fibers and/or dust. The condition causes cancerous cells to form on the internal lining of the lungs and, after 10 to 30 years, signs and symptoms of the condition begin to develop. Because mesothelioma cancer remains largely in a dormant state for the duration of its life in a victim, by the time its symptoms develop it is often untreatable.

Individuals who suffer from the deadly cancer should consider speaking with an experienced mesothelioma lawyer as to the details surrounding a potential mesothelioma lawsuit. Such a meeting could benefit anyone suffering from mesothelioma symptoms by resulting in monetary compensation, which may assist a victim in receiving expensive and potentially life-saving treatments.

LegalView also offers an array of other legal topics available through its LegalView library. For example, the site has made available the latest information on brain injury treatments as well as information on controversial prescription drugs such as Chantix and Singulair, which have both been linked to suicidal thoughts and tendencies among patients, according to U.S. Food and Drug Administration reports.

LegalView recently updated its TBI information portal with a new therapy known as hyperbaric oxygen therapy (HBOT), which is often used among divers when bends occur. However, new research is finding that HBOT may offer success among brain injured victims by administering the therapy among U.S. soldiers as a brain injury treatment. To learn more of the treatment, visit the LegalView brain injury information portal at http://brain-injury.legalview.com/.

Both Chantix and Singulair have been linked to an increase of behavioral and mood disorders as well as depression, increased suicidal tendencies, thoughts and actions; although both drugs treat very different conditions. Chantix is a smoking cessation drug that has been prescribed to nearly 4 million U.S. citizens whereas Singulair is used to treat allergies and asthma among Americans. If a victim suffers from either the Chantix risks or the Singulair side effects, they are encouraged to locate an experienced pharmaceutical attorney for assistance on developing a potential class action lawsuit.

About LegalView

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Contact Information
LegalView
Katie Kelley
720-226-6613
press-releases@legalview.com
http://mesothelioma.legalview.com

Personal Property Insurance Coverage Expands

noreply@blogger.com (Thuenthkin Anbelos) — Sun, 03 Jan 2010 20:52:00 +0000

Independent Mutual Fire Insurance Co. Launches New Website to Expand Personal Property Coverage

Independent Mutual Fire Insurance Co., a leading personal property insurance company, recently launched a new website, expanding personal property coverage to a wider range of agents & policyholders.

Baltimore, MD, January 02, 2010 -- Independent Mutual Fire Insurance Company, a leading personal property insurance company providing fire and smoke insurance, tornado insurance, hurricane insurance and more, has recently launched its new website, http://www.imfco.net.

The launch of the new website marks two important milestones for Independent Mutual. Not only does it allow Independent Mutual to experience more accelerated growth on a national level, but the new website also gives Independent Mutual the ability to offer its products and services to both captive and independent agents.

"Our top priorities at Independent Mutual have always been flexibility and fairness towards policyholders and agents alike," reports Scott Sauls, Vice President of Field Support at Independent Mutual. "The website will allow us to offer our personal property insurance products and services to a wider audience. In doing so, we will continue to focus on providing superior levels of customer service to both policy holders and agents."

According to Sauls, the new website offers innovative features that will enable Independent Mutual to offer an unprecedented level of customer service. "Both agents and policyholders can log into customized portals and receive 24/7 access to view the status of their claims reports and adjustments," he says. "We employ real-time claims adjustment technology and provide agents with the ability to instantly quote and issue policies right from their desktop through our AgenTreeT system."

"The new website offers an exciting opportunity for Independent Mutual to provide agents and policyholders with greater fairness and accuracy through the use of technology," Sauls says. For more information about Independent Mutual Fire Insurance Company, please visit http://www.imfco.net or call 800-248-7072.

About Independent Mutual Fire Insurance Company
Established in 1948 and headquartered in Cook County, Illinois, Independent Mutual Fire Insurance Company has been a leader in personal property insurance for over sixty years. Independent Mutual's Executive Office is located in Baltimore, Maryland and offers flexible, comprehensive personal property coverage throughout the United States.

Independent Mutual Fire Insurance Co. is rated as A- (Excellent) by A.M. Best Company. Known for its modest underwriting leverage, irrefutable market expertise, solid investment earnings and long-standing presence in the home service fire and burglary market sector, Independent Mutual provides personal property insurance to policyholders regardless of income or credit history. For more information about the personal property coverage offered by Independent Mutual Fire Insurance Company, please visit http://www.imfco.net or call 800-248-7072.

Contact Information
Independent Mutual Fire Insurance Company
Scott Sauls
800-248-7072
imfconet@gmail.com
www.imfco.net

Mesothelioma Cancer Advocate, Doctor, and Volunteers Recognized

noreply@blogger.com (Thuenthkin Anbelos) — Fri, 26 Jun 2009 05:39:00 +0000

Mesothelioma Doctor, Advocate and Volunteers Recognized by the Mesothelioma Applied Research Foundation

The Mesothelioma Applied Research Foundation will present three awards at the International Symposium on Malignant Mesothelioma on Friday, June 26th in Washington, DC. This year's award recipients include Dr. Robert Taub, Terry Lynch, and Craig & Shelly Kozicki. Galvanizing our community's tremendous diversity, talent, strength and knowledge is the key to developing more effective mesothelioma treatments and, one day, the cure. I am proud to be a part of this vibrant and dedicated community and I applaud this year's award recipients

Santa Barbara, CA (PRWEB) June 22, 2009 -- To recognize the extensive studies, long hours and personal investment of those involved in eradicating mesothelioma, the Mesothelioma Applied Research Foundation will present three awards at the Gala Celebration of Hope on Friday June 26th, day two of the International Symposium on Malignant Mesothelioma, to be held Thursday, June 25th through Saturday, June 27th at the Omni Shoreham, in Washington, DC.

"Galvanizing our community's tremendous diversity, talent, strength and knowledge is the key to developing more effective mesothelioma treatments and, one day, the cure. I am proud to be a part of this vibrant and dedicated community and I applaud this year's award recipients," says Dr. Nicholas Vogelzang, Chairman of the Meso Foundation's Board of Directors.

The Pioneer Award emphasizes the contributions of Dr. Robert Taub, MD PhD, whose treatment protocols and vision have shown remarkable results and have been the basis of hope for many mesothelioma patients; The Bruce Vento Hope Builder Award, named for the late Minnesota Congressman who died from mesothelioma in 2000, acknowledges the support and initiatives of Terry Lynch, International Vice President, Political & Legislative Director and Health Hazard Administrator of the International Association of Heat and Frost Insulators and Allied Workers; and The Volunteer of the Year Award honors Craig and Shelly Kozicki for being an inspiration to the mesothelioma community through their continued dedication in raising research funds and providing support and hope to others faced with mesothelioma. Craig, who had been diagnosed with mesothelioma in 1998, died in May of this year.

The Symposium, organized annually by the Mesothelioma Applied Research Foundation, will highlight the latest advances in research and treatment for patients and caregivers, offer psychosocial support to them as well as those who have lost someone to the disease, and provide all who are intent on eradicating the vicious and terminal effects of this tragic cancer with significant advocacy and volunteer opportunities. The three-day conference is dedicated to mesothelioma science, advocacy, and community.

Those wishing to attend can register for the symposium and get additional information on the Meso Foundation's website.

The Mesothelioma Applied Research Foundation is the national non-profit dedicated to finding a cure for mesothelioma by funding mesothelioma research, providing mesothelioma patients support services and participating in federal mesothelioma advocacy. Visit www.curemeso.org for more information.

CONTACT INFORMATION
Maja Belamaric
Mesothelioma Applied Research Foundation (Meso Foundation)
(805) 456-7272

Asbestos Bondage Studied

noreply@blogger.com (Thuenthkin Anbelos) — Mon, 08 Jun 2009 19:14:00 +0000

Asbestos Fiber Links With The Human Cells

2009-06-07 (WiredPRNews.com - Mesothelioma Asbestos, Press Releases)Dallas, TX: The Ohio University team of scientists are trying to establish individual bondage of the asbestos fiber and the human cell. There are two major forms , under their observation. Both of these forms are linked with the exposure of asbestos. Those people, who work at the asbestos job sites are the main targets. The onset takes place due to the inhalation or the swallowing of the tiny, microscopic fibers. These two forms of diseases are:

Asbestosis: It's a chronic respiratory disease. The attack is on the respiratory track, and it proves fatal. No cure has been discovered so far.

Mesothelioma: This infection can be of the lungs, chest or of the heart. There is no cure for this disease, too, and the prognosis is of six to twelve months, once the symptoms appear.

Asbestos occurs in six different forms, in nature, all these forms have proved deadly. Due to its qualities of durability and high resistance, it was widely used in a number of industries, till the first half of the last century. By the year 1940, it was totally banned in about forty countries of Europe and the United States, but asbestos is still present inn the manufactured stuff and is considered dangerous to human life. The breaking of the asbestos-related goods and the demolition of old buildings and structures, spread the dust and the fiber into the open atmosphere.

The team of scholars is using the 'Atomic Force Microscopy' to study, as to how a single fiber, during the exposure, after inhaling, clings itself with the cell surface of the lining of the organs.

One of the research candidates, has described this study as a type of 'braille work between the two ends of this bondage and says that the scientists will feel and observe, how the asbestos links with the human cells.

The U.S, Department of labor estimates about 1.3 million people will be the target of this disease in the coming years. This is the number of the labor exposed to asbestos, from 1960s up to '80s.

Medical Brokers Launches Medical Businesses and Real Estate Website

noreply@blogger.com (Thuenthkin Anbelos) — Sun, 19 Apr 2009 17:01:00 +0000

United Medical Brokers Launches Website Dedicated to Purchase and Sale of Medical Related Businesses and Real Estate

New York, NY, April 01, 2009 -- United Medical Brokers announced its nationwide launch today from its corporate headquarters. United Medical Brokers www.unitedmedicalbrokers.com is now offering nationwide brokerage services for buyers and sellers of medical practices, medical related businesses, and medical related real estate.

The company is a division of Bridge Business and Property Brokers which is a leading business brokerage firm. Bridge was recently named to the INC 500 list of fastest growing companies. Currently there is no firm that offers nationwide support for buyers and sellers of medical related businesses.

United will maintain medical transaction specialists at each of its offices to support the diverse needs of medical business clients. The Managing Partner of the firm is Robert Flynn who spent most of his career with the publicly traded $3 billion London based Cookson Group plc as a senior executive; he brings decades of transaction related experience to the company.

The firm's growth strategy includes affiliations with leading national providers of medical business related services that are positioned to quickly identify medical related transaction opportunities. Prudential Real Estate has joined as an affiliate to serve the medical related real estate needs of United Medical Broker clients across the United States. Priority Leasing is also affiliated to provide medical equipment financing services.

"I am very excited about this expansion of our successful brokerage model. Medical related businesses continue to prosper during these difficult economic times. The long-term fundamentals look exceptionally positive and we are positioned to capitalize on them. Near term the health related policies being planned and executed by the new presidential administration will create further demand for our services," said A.J. Caro, founder of Bridge Business and Property Brokers.

Bridge's President also voiced excitement stating, "The launch of this division shows our commitment to dominating the marketplace by offering expert services to specific vertical markets."

For more information visit the company website at www.unitedmedicalbrokers.com

Contact Information
United Medical Brokers
Robert A. Flynn
401-744-0320
rflynn@unitedmedicalbrokers.com
unitedmedicalbrokers.com

Truck Drivers At Greater Risk For Lung Cancer

noreply@blogger.com (Thuenthkin Anbelos) — Mon, 06 Apr 2009 15:09:00 +0000

Diesel Users Suffer More Lung Cancer; a Simple Solution is to Hand from ChemEcol and VEPower

Those who work with and at close proximity to diesel engines, especially lorry drivers, are at a higher risk of cancer according to a recent US study. This is on top of the elevated risk of "heart disease and stroke, possibly resulting from enhanced coagulation and arterial thrombosis" such exposure gives. The good news is that a British company has developed a fuel technology that is seen to significantly reduce ultra fine particulate emissions by as much as 45%.

Welwyn Garden City, United Kingdom, March 28, 2009 -- Truckers endure such grave risks as lung cancers, heart disease and stroke all the time they run their engines. But it's not just the lorry drivers who are at risk. The American study also saw that those working with the and near trucks (fork truck drivers, warehousemen, mechanics, and even office workers) are at elevated risk from these killers. Why?

Diesel exhaust carries particulate matter; this is what colours it smoky black. Particulates are both created by and carriers of toxic substances called polycyclic aromatic hydrocarbons (PAHs). Many of these are known to be particularly carcinogenic, mutagenic. Some of these particles are small enough (100nm or less) to be classified as nanoparticles. These have been found to become distributed around the body via the blood supply once inhaled with notable deposits being found in the liver and heart. If ingested (when particles have settled on food or in drink) they will also pass into the gastro-intestinal tract (4).

It's not just haulage workers and their colleagues who are at risk. Black carbon (again, part of the exhaust) exposure in city children has been shown to reduce development in terms of intelligence (5). The particulate matter we have been looking at is known also to exacerbate respiratory complaints, allergies such as asthma and may agitate some skin complaints also. Some studies have found that certain particulate constituents can be carcinogenic on the skin as well as when inhaled (6).

ChemEcol (UK) Ltd. makes the combustion enhancer Additone. The technology has been developed as a response to the grave threats posed by vehicle exhaust pollution. ChemEcol's products are not based on metallic catalysts, nano-technology or otherwise, as such would counteract the goal of reducing particulate pollutant emissions (the metallic particles would be exhausted along with the other emissions). In fact this technology is based on pure hydrocarbon formulations, maintaining the physical properties of the diesel.

ChemEcol's patented technology modifies the processes of fuel combustion inside the engine, reducing the particulates produced at the most fundamental level. This has a beneficial side-effect of reducing fuel consumption as the PAHs otherwise produced can be considered to be wasted fuel. This change then reduces CO2 emissions and costs by an average of 3%.

VEPower Ltd markets ChemEcol's product. They can be reached at ChemEcol on +44 (0) 1707 330400, at www.chemecol.net and neil@chemecol.net.

Contact Information
ChemEcol Ltd
Nel Faulkner
+44 (0) 20 3286 8771
neil@chemecol.net
www.chemecol.net

No Apology From Allina For 18 percent Interest Rate

noreply@blogger.com (Thuenthkin Anbelos) — Thu, 22 Jan 2009 23:22:00 +0000

Allina Hospitals & Clinics Responds to Attorney General's Suit

MINNEAPOLIS - January 2009 -- In response to a lawsuit filed today by the Minnesota Attorney General's Office, Allina Hospitals & Clinics made the following statement:

"Allina Hospitals & Clinics is surprised by the Attorney General's action today. Allina had been analyzing various proposals to modify MedCredit's interest rate structure for some time, and prior to the filing of this suit, Allina had made the decision to reduce the interest rate on all current and future MedCredit accounts to eight percent, regardless of the size of the balance. Allina communicated this to the Attorney General in December of 2008. Allina believes that this new rate structure is in the best interests of our patients who would benefit from the ability to pay their medical bills over time.

"While Allina believes the new rate of eight percent is appropriate going forward, it should be noted that the previous rate structure, which included a sliding interest rate scale based on the balance due, was fully consistent with Minnesota law, and was clearly communicated to all patients who participated in the program. The program is considered "open-ended credit," meaning that patients can use the program on an ongoing basis for subsequent care. The rates previously charged by Allina are consistent with Minnesota law for this type of credit.

Allina believes that MedCredit remains a valuable tool to help some patients pay their medical bills and that it may be a better alternative to financing such debt through a credit card, which may charge a much higher interest rate. Allina does not deny care to anyone based on inability to pay, and works with patients to help ensure they receive all possible forms of assistance in paying their medical bills, including free care or government assistance programs. Allina offers free care to individuals and families whose income is less that 275 percent of Federal poverty guidelines.

"Allina believes the allegations contained in the complaint are without merit and that the MedCredit program is fully compliant with the law. Allina looks forward to discussing this matter further with the Attorney General, and bringing it to a timely resolution."

Allina Hospitals & Clinics is a not-for-profit health care system of hospitals, clinics and other patient care services that provides exceptional care to communities throughout Minnesota and western Wisconsin and employs more than 22,000 people. Allina Hospitals & Clinics facilities, services and jobs can be found online at www.allina.com.

Contacts

Allina Hospitals & Clinics
David Kanihan, 612-262-4986
david.kanihan@allina.com
Cell: 612-867-2845

The lawsuit names as defendants both Allina Health System and its subsidiary, Accounts Receivable Services, a debt collection agency owned by Allina that does business under the name MedCredit Financial Services. It seems odd to me that they lowered the rate to 8% which happens to be the legal limit. As a non-profit perhaps they should consider lowering the rate still further, since that could only be in the best interests of their clients...

Medical Billing On-Line
Cold Hard Cash
Billing Computer Medical Software
Where To Sell Gold

Avandia May be More Dangerous Than Previously Thought

noreply@blogger.com (Thuenthkin Anbelos) — Wed, 10 Dec 2008 21:05:00 +0000

LegalView Updates Avandia Information Portal with News That Avandia May be More Dangerous Than Similar Drugs

LegalView recently relaunched is Avandia information portal with updated news that the type 2 diabetes drug has more safety risks than drugs of a similar nature. A study from U.S. researchers was published evaluating the dangers of the diabetes drugs and found Avandia as riskier for patients than Actos.

Denver, CO, December 02, 2008 -- LegalView.com, the number one resource for everything and anything legal on the Web, recently announced an update to its Avandia information portal with news that the type 2 diabetes drug poses more safety risks to patients than similar drugs including Actos. According to a Reuters article published in November, the Avandia study as well as analysis has been conducted of the drugs and has found that of both Avandia and Actos, Avandia poses greater risks, especially among older-aged diabetic patients and that the risks include an increased chance of developing heart disease.

Individuals who consume Avandia and who are concerned about the Avandia side effects, which may potentially include early on-set osteoporosis as well as heart failure, according to the New England Journal of Medicine, may need to discuss discontinuing use of the drug with a medical professional. Additionally, contacting an experienced pharmaceutical and Avandia attorney who may be able to provide a free legal consultation as to the development of a potential Avandia class action lawsuit.

Avandia was first introduced from GlaxoSmithKline in May 1999 and was prescribed to nearly 3 million type 2 diabetes sufferers. In 2007 a U.S. Food and Drug Administration (FDA) health advisory alert was issued regarding the discovery of the alleged link that Avandia patients may be at a greater risk for developing heart disease and heart failure, while also being more susceptible to broken bones and fractures due to a potential osteoporosis risk. Patients consuming the drug should speak with their physician as well as consider the development of litigation for the potential of earning monetary compensation.

LegalView has also made available information portals on several other topics ranging from information on traumatic brain injuries to other controversial pharmaceutical drugs such as Byetta and Ketek.

According to the Brain Injury Association of America, approximately 1.4 million Americans suffer from a traumatic brain injury each year. The condition has also been deemed the signature injury of the war in Iraq by news organizations and medical professionals. Additionally, thousands of individuals are not treated for their TBI condition, which could cause a worsening of the TBI side effects among patients. It is imperative that an individual who may have suffered from a TBI accident contact a medical professional regarding their potential condition.

Byetta (exenatide) from Amilyn Pharmaceuticals and Eli Lilly was released in 2005, however, the type 2 diabetes drug was allegedly under investigation by the FDA for the potential link to pancreatic inflammation among Byetta patients. In August 2008, approximately six individuals consuming the drug had developed acute pancreatitis and of the six, two had died. Patients of Byetta who are concerned about the potential dangers allegedly associated with the drug are advised to contact a Byetta law firm for more information.

Ketek, which has been available since 2004 from Sanofi-Aventis, has been allegedly linked to the development of liver damage among patients who have consumed the antibiotic that treats upper respiratory infections such as bronchitis and community acquired pneumonia. The FDA is also currently investigating the drug, but those who have been affected by the Ketek side effects are encouraged to contact a medical professional as well as a pharmaceutical attorney.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Contact Information
LegalView
Katie Kelley
720-226-6613
press-releases@legalview.com
http://avandia.legalview.com

Study Investigates Link Between Genetic Predisposition and Mesothelioma Cancer

noreply@blogger.com (Thuenthkin Anbelos) — Fri, 28 Nov 2008 05:21:00 +0000

LegalView Reports Results of a Breakthrough Study Investigating Link Between Genetic Predisposition and Developing Mesothelioma Cancer

LegalView informed readers to the results of a scientific investigation studying the potential link between genetic components and developing mesothelioma cancer. Scientists determined that genetic responses occurred after a specific type of asbestos was introduced to cells within the lining of the lungs.

Denver, CO, September 01 -- LegalView.com, the number one legal resource available on the Web, offered updated details on its mesothelioma information blog of an advanced scientific investigation studying the link between asbestos and genetics. Researchers, who found a genetic response to a specific type of asbestos known as crocidolite, published their findings in an August 2008 issue of BMC Genetics. The study, a first of its kind, used a methodology of exposing cells within the human lung lining to asbestos and then scientists watched the reaction and changes. The study offers mesothelioma victims a unprecedented look into how asbestos affects the human body. Victims were also provided with a gleam of progress on finding a cure for the condition, although the scientists stated more research is required.

Individuals who are suffering from an asbestos-related disease are advised to contact a mesothelioma law firm that can provide access to a wealth of knowledgeable mesothelioma attorneys. Because mesothelioma cancer is incurable and is commonly considered a preventable illness, discussing the details of a potential mesothelioma lawsuit with a mesothelioma lawyer may provide insight as to how monetary compensation could be awarded to aid in the costly medical bills associated with mesothelioma.

In their study, the researchers reported that asbestosis occurs in nearly 200,000 individuals each year with an additional 4,000 asbestos-related deaths occurring annually as well. Asbestos is a type of mineral that was mined for use in insulation because of its fire-retardant qualities and inexpensive production costs. However, inhaling asbestos fibers has led to a severe and incurable form of lung cancer known as mesothelioma. Millions of Americans may have been exposed to asbestos fibers during the 20th century, as asbestos was heavily mined and often used during the construction of buildings such as elementary schools, universities, hospitals, office buildings, homes and apartments.

In addition to mesothelioma information, LegalView houses a library of other legal issues potentially causing harm to everyday Americans. Also, due to the ongoing crisis among the pharmaceutical community, LegalView has provided updated information on several pharmaceutical drug's side effects and dangers. Among the drugs are Ketek as well as Levaquin and Cipro, both of the fluoroquinolone family.

Ketek (telithromycin) is an antibiotic used to treat conditions such as community-acquired pneumonia, bronchitis, sinusitis and other upper respiratory infections. The antibiotic is manufactured by Sanofi-Aventis and has been available to the market since 2004, however, since its release, the U.S. Food and Drug Administration (FDA) has reported nearly 20 deaths of individuals consuming the medication. The deaths all involved the development of liver damage among the patients who died as well as an additional 100 patients who also reported signs and symptoms of liver disease while taking Ketek. Those who have consumed Ketek and feel they exhibit any of the side effects commonly associated with liver disease, such as jaundice or yellowing of the skin, should seek medical assistance immediately. Additionally, it may be advisable for an individual to be involved with a Ketek class action lawsuit and contacting an experienced pharmaceutical lawyer will assist with any legal action necessary.

Levaquin (levofloxacin) and Cipro (ciprofloaxacin), similar to Ketek, are also antibiotics that treat bacterial infections such as bronchitis, although, in July 2008 the FDA gave all of the fluoroquinolone drugs an increased warning label known as the "black box" warning label, the harshest warning given by the FDA. The warning label was increased because the Levaquin and Cipro risks had been previously linked to tendon rupture among patients, according to several studies including one published in Clinical Rheumatology in February 2004. The black box warning is to encourage physicians to avoid prescribing these drugs to patients who may be at a greater risk for Achilles tendon rupture, including elderly patients.

LegalView provides a vast array of resources for individuals plagued by legal misfortune so that they may positively improve their situation and have the tools necessary to do so, including the recently updated Zimmer Durom cup information portal. The Zimmer Durom cup is an artificial hip component used during hip replacement surgery among patients. However, Zimmer Holdings, manufacturers of the product, recently halted the production of the hip socket after hundreds of doctors complained that the medical device was failing among patients. To learn more about the potential for a Zimmer Durom cup recall, visit the LegalView homepage at http://www.LegalView.com/.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com
www.legalview.com

Mesothelioma Treatment Video
Bengoshi-san
Accident Injury Compensation

Visual Reference for Neurosurgeons Published

noreply@blogger.com (Thuenthkin Anbelos) — Thu, 27 Nov 2008 04:51:00 +0000

A Concise and Visual Reference for Neurosurgeons Published in Conjunction with the American Association of Neurological Surgeons

New York, NY, November 26, 2008 -- Every year approximately 30,000 patients in the United States suffer from a ruptured cerebral aneurysm. And according to the American Association of Neurological Surgeons (AANS), up to six percent of the population may have an unruptured one. Managing such a serious medical condition poses significant challenges for patients as well as their treating physicians. Vascular Neurosurgery, co-published by Thieme and the AANS, includes one section devoted to aneurysms and subarchnoid hemorrhage. The book is a step-by-step guide to management, preoperative evaluation, surgical technique, and postoperative management. It is currently the only text in the field that provides concise visual chapters on how to carry out such surgical procedures.

The second edition of Vascular Neurosurgery is a new volume in the classic Neurosurgical Operative Atlas series. This detailed atlas, which offers surgical approaches to common neurovascular diseases and conditions, was developed to "meet the needs of residents and neurosurgeons particularly when it comes to learning how to conduct an operation, brushing up on a technique, or just finding out how others do things," says editor Dr. R. Loch Macdonald, head of the division of neurosurgery at the University of Toronto, in Toronto Ontario.

The book contains more than 300 illustrations that vividly demonstrate surgical steps and techniques. One of the many appealing aspects of the atlas lies in its brevity. Each chapter can be read within thirty minutes, enabling a physician or resident to quickly page through the book prior to surgery.

This practical surgical reference is not only useful for prepping for oral board examinations; it is also an asset to clinicians in neurosurgery and vascular surgery. Vascular Neurosurgery is one in an ongoing series of books co-published by Thieme and the American Association of Neurological Surgeons. The five volume set, edited by leading experts in the field, covers the entire spectrum of neurosurgery. Other titles in the series include, Neuro-Oncology, Spine and Peripheral Nerves, Pediatric Neurosurgery, and Functional Neurosurgery.

About the American Association of Neurological Surgeons

The American Association of Neurological Surgeons (AANS) is the organization that speaks for all of neurosurgery. The AANS is dedicated to advancing the specialty of neurological surgery in order to promote the highest quality of patient care.

About Thieme

Thieme Publishing Group is a privately held scientific and medical publishing house employing more than 950 people and maintaining offices in seven cities, including New York, Delhi, Stuttgart and three other locations in Germany. Founded in 1886, the Thieme name has become synonymous with high quality and excellence in medical and scientific publishing. Today, Thieme is the market leading publisher of neurosurgical content and holds strong market positions in orthopedics, radiology, anatomy and chemistry, among other specialties. Thieme publishes 137 peer-reviewed journals and over 500 new books annually. The company also has a rapidly growing array of web-based products in medicine and science. Popular online products include Thieme eJournals and the Thieme Electronic Book Library, which are accessible via thieme-connect.com, Thieme's platform for electronic products. New anatomy resources include the thiemeteachingassistant.com for faculty, and winkingskull.com for students. Please visit thieme.com for additional information.

Contact Information
Thieme Publishers
Bettina Ziegler
+49-711-8931-488
bettina.ziegler@thieme.de
www.thieme.com

Manufacturing Simulation Software
Steam Shower Saunas
Heat Pump Technology
Mesothelioma Prognosis

Market Growing For Surgical Sealants, Glues, Wound Closure, and Anti-Adhesion Products

noreply@blogger.com (Thuenthkin Anbelos) — Tue, 18 Nov 2008 21:34:00 +0000

Surgical Sealants, Glues, Wound Closure, Anti-Adhesion, Worldwide; MedMarket Diligence Report

MedMarket Diligence tracks wound closure, hemostasis and anti-adhesion technologies and forecasts this market in a forthcoming worldwide report, with insight into market introduction, growth, competition and business opportunity.

Foothill Ranch, CA, November 18, 2008 -- Opportunities for products in wound closure, hemostasis and anti-adhesion products are plentiful for established and emerging companies, driven by innovation in product formulation and penetration of more caseload, including growth in more medical and surgical specialties. The market for these products is also growing through their expansion globally, with products being introduced and finding clinical acceptance in the U.S., Europe, Central and South America and other markets globally.

MedMarket Diligence monitors and identifies emergence and growth of novel technologies in wound closure, hemostasis and anti-adhesion and applies its industry awareness and analysis to providing insight into market introduction, growth, competition and opportunity worldwide. The products, current and forecast markets, companies and opportunities are detailed in this 2008 report from MedMarket Diligence. The report details the markets worldwide, with detailed geographic segmentation, for surgical sealants, glues, hemostats, sutures, tapes, and other wound closure technologies, as well as products for the prevention of post-surgical adhesion.

"The use of these biologicals and other product forms, once representing a minor share of wound closure, has now moved into the mainstream, with sealant, closure, hemostasis and combinations of uses by these products eclipsing use by traditional wound closure devices," says Patrick Driscoll, president of MedMarket Diligence. According to Driscoll, the market is also experiencing increased competition and market evolution as new products are introduced and some consolidation is taking place even while the number and types of procedures target by these products proliferate. A number of market leaders have solidified their positions within the surgical closure and securement markets through successful internal development programs and through technology partnerships with innovative vendors of next generation technologies.

MedMarket Diligence's comprehensive analysis of the market for surgical sealants, glues/adhesives, hemostats, tapes, sutures, and anti-adhesion products is a worldwide report that is a must have tool for market planning, strategic analysis and positioning in this large and growing market. The report details the products on the market, their current and forecast penetration of clinical application, new products under development and their status, the current and forecast market for products by major country markets worldwide, and the current and hopeful competitors in the market and their positions, strengths and strategies. The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, Germany, France, Italy, BeNeLux), Latin America, Japan and Rest of World.

The report is scheduled for publication in early December 2008. The report is described with table of contents (list of exhibits pending) at http://mediligence.com/rpt/rpt-s175.hm. A pre-paid discount is available and the report may be purchased at https://www.mediligence.com/store/page29.html or via order form (http://www.mediligence.com/order_forms/s175_order.pdf).

Contact Information

MedMarket Diligence, LLC
Patrick Driscoll
949-859-3401
patrick@mediligence.com
www.mediligence.com

Compulsive Gamer
Validation Company
Accident Lawyer Minneapolis
Lower Back Pain

Charity Helps Millions Left Starving by Health Insurance

noreply@blogger.com (Thuenthkin Anbelos) — Sun, 21 Sep 2008 04:01:00 +0000

Local Charity Helps "Feed" the Millions Left "Starving" by Health Insurance

Manna Scholarship Fund was formed in 2007 as a 501(c)3 organization focused on filling the funding gap for individuals needing inpatient eating disorder treatment. Because insurance policies will rarely cover the cost of successful inpatient treatment, MSF is attempting to "fill the funding gap" for those in need of treatment. Manna Scholarship Fund is hosting a fundraising dinner "Manna in Motion" to promote the scholarship fund and to raise awareness of this great need to the public.

Atlanta, GA, September 11, 2008 -- Who: Manna Scholarship Fund was formed in 2007 as a 501(c)3 organization focused on filling the funding gap for individuals needing inpatient eating disorder treatment.

Why: Because the Health Insurance industry does not understand the significance of adequate eating disorders treatment, insurance policies will rarely cover the cost of successful inpatient treatment. This cost can be between $800-$2000 a day, with appropriate treatment ranging from 60-90 days, and often longer. This puts families of these sufferers in grave danger. Statistically, this illness is extremely significant because "anorexia has the highest premature fatality rate of any mental illness" (Sullivan, 1995). Without assistance, those in need of this type of inpatient treatment will have no other option but to pay the full price of treatment.

Being awarded a Scholarship from the Manna Fund provides the scholarship winner with:

· An active role in the choosing the treatment facility
· The opportunity to receive adequate, life-saving care
· Options to extended treatment that previously weren't available through the health insurance and/or to patients that have no inpatient benefits
· A greater chance of recovery due to access to the In-Patient services
· The opportunity to gain wholeness and in turn give back to others in need.

How: In order to provide adequate eating disorder treatment for those in need, Manna Scholarship Fund seeks to raise funds through many avenues, including in-kind donations, outreach programming that focuses on family investment (jewelry-making parties, bowling tournaments), corporate sponsorships, and grants. Manna Scholarship Fund has raised nearly $100,000 for scholarships in the past year and a half, supplying three individuals with the necessary inpatient treatment and reaching a hundred families through outreach. As the word has gotten out about the existence of this fund, scholarship application submission has sky-rocketed.

What/When: In order to contribute to this need, Manna Scholarship Fund is hosting a fundraising dinner "Manna in Motion" to promote the scholarship fund and to raise awareness of this great need to the public. This event will be held on Thursday, September 25th at the 1420 Room at 1420 Dunwoody Village Parkway, Dunwoody, Georgia.

At this event, guest speaker, Barbara Gaby of the Gaby Foundation, will discuss her journey through her own eating disorder as well as what it was like to be a part of a prominent family while enduring an eating disorder. Guests will also hear from Genie Burnett, the Executive Director of the MSF, in regards to the mission and vision of the MSF, as well as outreach and ongoing fundraising efforts. Guests will also be entertained by surprise performances as well as a jazz quartet. In efforts to raise funds for MSF, Manna in Motion will also hold a silent auction.

For more information about the Manna Scholarship Fund and the upcoming fundraising event, please go to www.mannafund.org, or contact Jesse Stanford at jstanford@mannafund.org or @ (404)-665-7725 The Manna Scholarship Fund, Inc. 2250 Satellite Blvd, Suite 100, Duluth, GA 30097.

Headliners:

· Up to 10 million people each year suffer from eating disorders while their health insurance leaves them paying the bills.
· Without treatment up to 20% of people with serious eating disorders die. With treatment that number falls to less than 3%.
· A local charity Manna Scholarship Fund bridges the gaps in patient's ability to pay for necessary treatment.
· Founded by Dr. Genie Burnett and Leslie Cox RD, LD in 2007, the Manna Scholarship Fund focuses on education, awareness, and action in offsetting the exorbitant cost of treatment.
· Recognizing the hidden "holes" in the typical health insurance coverage, Dr. Burnett and Mrs. Cox chose to go about fixing the problem the only way they knew how and not with the indifference that the Health Insurance Industry displays.
· The huge number of potential recipients that could benefit from a scholarship is simply so big that the Scholarship Fund needs your donations.

Contact Information

Manna Scholarship Fund, Inc
Dr. Genie Burnett, Executive Director
(404)-665-7725
info@mannatreatment.org
www.mannafund.org
770-495-9775

Laser Hair Removal Threatened by Common Dangers

noreply@blogger.com (Thuenthkin Anbelos) — Sat, 13 Sep 2008 04:39:00 +0000

New Route to Hair Free Skin - But Are You At Risk of Serious Complications?

In the USA in 2007 nearly 1.5 mil. laser hair removal procedures were carried out. Shockingly a staggering 19.9% of patients undergoing these procedures experience complications. LaserHairRemoval-Info.com was founded in 2005 to provide consumers with little-publicized information on laser hair removal, and is launching a new book aiming to bring the knowledge needed by consumers out from behind the locked doors of the laser clinics and places it firmly in the hands of those that need it.

New York, NY, September 12, 2008 -- Success of Laser Hair Removal Threatened by Increasingly Common Dangers and Widespread Ignorance.

The removal of unwanted hair using lasers is becoming increasingly commonplace; in the USA in 2007, nearly 1.5 million laser hair removal procedures were carried out1 and shockingly a staggering 19.9% of patients undergoing these procedures experience complications2.

Increasingly consumers are having to take their fate into their own hands and perform the research and investigation necessary to ensure that they receive the appropriate treatment rather than relying on the dubious expertise of some of the laser hair removal clinics, many of which are not operating under the direct supervision of a qualified doctor or dermatologist.

"I never want to go near a laser again," says former laser hair removal patient Andrea (age 43) of Brooklyn, New York. After undergoing treatments totaling $2,900 in cost over the course of a year, Andrea has now reverted to shaving her unwanted body hair as the treatment was almost completely ineffective. "The wasted money, although it is a lot of money to me, is irrelevant compared to what I have suffered in pain and embarrassment undergoing treatment after treatment which initially had no effect at all and then when the laser strength was increased resulted in sore, unsightly burns."

Now a brand new report has been created, aimed squarely at consumers who want to get laser hair removal without the risk of side effects or ineffective treatment. Readers can download this free insider report, Top 10 Must-Know Tips on Laser Hair Removal, from http://www.laserhairremoval-info.com/download/booklet.htm. This no-nonsense guide will help patients to avoid the fate experienced by Andrea and ensure that they get the right laser hair removal treatment for their specific circumstances.

"Be prudent and selective when evaluating your options for any possible cosmetic procedure," advises dermatologist Gary Monheit, MD, president of the ASDS.

Patients must realize that just because a laser clinic near their home is offering treatment for a good price doesn't mean that this particular clinic possesses the expertise or the equipment to safely and effectively treat their skin type. The knowledge offered in the newly published book: Insider Secrets of Laser Hair Removal (available from September 2008) gives consumers the ability to understand the whole process of laser hair removal and how it will apply to their own physiology and specific goals.

LaserHairRemoval-Info.com was founded in 2005 to provide consumers with little-publicized information on laser hair removal. The site offers a range of articles, research materials and message forums for people considering this life-changing treatment.

Contact Information
LaserHairRemoval-Info.com
Ingrid Preube
49-531-577497
ingrid@laserhairremoval-info.com

Innovative Senior Services Company Launched

noreply@blogger.com (Thuenthkin Anbelos) — Sat, 13 Sep 2008 04:26:00 +0000

New Innovative Company Launch - Opt2Care, Senior Services

Opt2Care, Senior Services launches a new and innovated senior home care company in New Jersey.

East Orange, NJ, September 12, 2008 -- Opt2Care Senior Services is not another home care company. The difference is in the founder's commitment, services provided, and the quality of staff that provide senior care services.

Collectively, the founders, Melissa Louie and Gerry Sayco, have over 20 years of relevant health care industry experience. Melissa Louie, LMSW, MPA, has worked in the healthcare field since 1992. Her passion to make a difference in the field of aging stems from her close relationship with her grandmother. While caring for her grandmother, she recognized the need for competent and compassionate clinicians in the field of aging. For the past 13 years, she has worked diligently to improving the quality of life for older adults and their families. For example, Melissa was employed as Program Director at Chelsea Adult Day Health Center; Eldercare Coordinator for Catholic Charities; and as a Medical Social Worker at Dry Harbor Nursing Home.

Gerry Sayco is an accomplished results-oriented business professional with over 12 years of operational excellence within the Pharmaceutical Industry. Gerry's close relationships with senior family members and friends of family helped him identify what was lacking in existing home care options and prompted him to pursue a home care service with "real" alternatives for today's world. Gerry expressed his strong dedication to this service by stating, "my goal is not only to apply the experiences and guidance I have received from mentors' within my career and family, but also to make a revolutionary difference in the Senior Home Care market."

Opt2Care (acronym for "Opt To Care") helps older adults achieve optimum health and well-being by blending traditional home care services and complementary therapies. Factors that contribute to the healing of the body, mind, and spirit are addressed. Complementary therapies include art, music, massage, Reiki, and Care Management.

Opt2Care encourages a collaborative team approach and employs only experienced practitioners and care providers that are dedicated to providing quality service that will help seniors remain independent in the community.

Opt2Care, Senior Services
PO Box 594, Eatontown, NJ 07724
888-678-2243
www.opt2care.com

Contact Information
Opt2Care
Gerry Sayco
888-678-2243
Contact@Opt2Care.com
www.opt2care.com

Medical and Practice Management Suite Client/Server Receives CCHIT Certification

noreply@blogger.com (Thuenthkin Anbelos) — Sat, 30 Aug 2008 22:16:00 +0000

LSS Data Systems' Medical and Practice Management (MPM) Suite Client/Server 5.54 Receives 2007 CCHIT Certification

Software Complies with 100 Percent of Updated 2007 Certification Criteria

EDEN PRAIRIE, minn.-- July 02, 2008 --The Certification Commission for Healthcare Information Technology (CCHIT®) announced yesterday that LSS Data Systems' product Medical and Practice Management (MPM) Suite Client/Server 5.54 is CCHIT Certified®, and meets the Commission's ambulatory electronic health record (EHR) criteria for 2007. Ambulatory EHRs are designed for physician offices and clinics where most Americans get their healthcare. CCHIT - an independent, nonprofit organization - is the Recognized Certification Body in the United States for certifying health information technology products.

In the second year of the program's operation, the criteria and testing have been significantly enhanced. The Commission added 96 criteria to the 151 original requirements from last year. Medical and Practice Management (MPM) Suite Client/Server 5.54 has been tested and passed inspection of 100 percent of a set of updated criteria for functionality, interoperability and security.

"For 2007, the Commission raised the bar from the previous year's criteria. Ambulatory EHRs now must include electronic prescribing, demonstrate an ability to receive lab results, and show enhanced patient safety, quality, and security features," said Mark Leavitt, M.D., Ph.D., chair, CCHIT. "Investment in 2007 certified ambulatory EHRs gives providers even more powerful tools to improve quality, safety and efficiency while protecting the privacy of health information."

The CCHIT Certified mark - a "seal of approval" for EHR products - provides the first consensus-based, government-recognized benchmark for ambulatory EHR products. By looking to products with the CCHIT Certified seal, physicians and other providers can reduce their risk in selecting an EHR product, allowing them to focus their evaluation on the special needs of their practices.

"This certification illustrates our ongoing commitment to provide the highest quality software for our customers. CCHIT certification is definitely something our customers value," said Bill Schmidt, Vice President of Sales & Corporate Development at LSS Data Systems. "We are delighted with the achievement of this milestone. We take pride in the strength of our products and the foundation of our seamless integration with MEDITECH to create one electronic health record across the health care enterprise."

LSS customer Parkview Adventist Medical Center, based in Brunswick, ME, recently updated to MPM Client/Server Version 5.54. "We congratulate LSS for 2007 certification of the MPM Suite," said Bill McQuaid, Chief Information Officer at Parkview. "One of Parkview's main approaches to care involves utilizing state-of-the-art technology to provide the highest quality care. It is important to us to use products which we know meet and exceed industry benchmarks."

CCHIT's certification compliance criteria and its design for a certification inspection process have been thoroughly researched, taking into account the state of the art of EHRs and available standards, and comparing certification processes in other industries and other countries. The inspection process is based on real-life medical scenarios designed to test products rigorously against the clinical needs of providers and the quality and safety needs of healthcare consumers and payers. One script, for example, recreates a scenario of an elderly man with poorly controlled diabetes, hypertension and other chronic conditions in order to test EHR functions such as potential adverse drug reactions, disease management and treatment plans.

About LSS Data Systems

LSS Data Systems, a MEDITECH partner founded in 1982, develops clinical, financial and administrative solutions for medical practice groups, healthcare delivery systems and clinics across the United States and internationally. Together with MEDITECH, LSS has developed the Medical and Practice Management (MPM) Suite, a full-featured ambulatory care solution that integrates physician practices and clinics with MEDITECH's Health Care Information System. The MPM Suite includes an ambulatory Electronic Health Record with prescribing/ordering, physician documentation, scanning, scheduling, billing and financial management tools. For more information please visit www.lssdata.com.

About CCHIT

The Certification Commission for Healthcare Information Technology (CCHIT®) is an independent, nonprofit organization that has been named by the federal government as the Recognized Certification Body for health information technology. Its mission is to accelerate the adoption of health information technology by creating a credible, sustainable certification program. The certification requirements are based on widely accepted industry standards and involve the work of hundreds of expert volunteers and input from a variety of stakeholders throughout the health care industry. More information on CCHIT and CCHIT Certified® products is available at www.cchit.org.

"CCHIT®" and "CCHIT Certified®" are registered marks of the Certification Commission for Healthcare Information Technology.
Contacts

LSS Data Systems
Megan Salmela, 952-941-1000
msalmela@lssdata.com
or
CCHIT
Sue Reber, 503-703-0813
sreber@cchit.org

Cancer Institute Receives Grant to Study Long-term Health Effects of Traumatic Brain Injuries

noreply@blogger.com (Thuenthkin Anbelos) — Sat, 30 Aug 2008 04:17:00 +0000

John Wayne Cancer Institute Receives Grant to Study Long-term Health Effects of Traumatic Brain Injuries

Research Will Focus on Relationship of Concussion, Pituitary Hormonal Failure and Quality of Life in Retired National Football League Players

SANTA MONICA, Calif.-- July 02, 2008--The John Wayne Cancer Institute at Saint John's Health Center announced today that it has received a grant from the National Operating Committee on Standards for Athletic Equipment to study pituitary hormonal failure (hypopituitarism) in retired football players.

The research, which will be conducted in collaboration with the University of North Carolina's (UNC) Department of Exercise and Sport Science, and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, will be directed by Daniel F. Kelly, MD, director of the Neuro-Endocrine Tumor Center at the John Wayne Cancer Institute, and Kevin M. Guskiewicz, PhD, chairman of the Department of Exercise and Sport Science at UNC.

In a cohort of retired National Football League (NFL) players, the study will examine the relationship between the number of concussions sustained in players' NFL careers, and their subsequent pituitary hormonal function and post-retirement quality of life. The investigators hypothesize that players sustaining multiple concussions are at increased risk of developing pituitary hormonal dysfunction which may in turn contribute to problems of obesity, fatigue, impaired metabolism, depression, sexual dysfunction and a general poor quality of life.

According to Dr. Kelly, the new study will focus on a relatively unexplored area of traumatic brain injury (TBI)-the potential correlation between recurrent concussions and pituitary hormonal dysfunction. More than 1.2 million Americans sustain a TBI annually, the majority of which are cerebral concussions. Repeat concussions have been shown to be a risk factor for neurodegenerative dementing disorders, including mild cognitive impairment and Alzheimer's Disease. However, little is known about the impact of single or multiple concussions on hormonal function and quality of life. Only in the sport of boxing, have a few small studies shown that boxers are at increased risk of developing pituitary failure. In contrast, it is well known that a single severe head injury can lead to pituitary damage and hormonal abnormalities in up to one third of individuals.

The pituitary is a small bean-shaped gland located immediately below the brain and behind the nasal cavity in the skull base; it is connected to the brain by the thin delicate vascular pituitary stalk. Weighing less than one gram, the pituitary is often called the "master gland" since it controls the secretion of the body's hormones. These essential substances when released by the pituitary into the blood stream have a broad range of effects on growth and development, sexuality and reproductive function, metabolism, the response to stress and overall quality of life.

"This research is long overdue," Dr. Kelly said. "Millions of young people and professional athletes participate in sports that put them at risk of concussion; not just football, but also hockey, rugby, soccer, baseball and basketball. We need to know more about how these so-called "minor head injuries" impact their lives in subsequent years, and in particular, whether multiple concussions can lead to pituitary hormonal failure and poor quality of life."

Using the database of the Center for the Study of Retired Athletes at University of North Carolina and in cooperation with the National Football League Players' Association, 90 study participants will be categorized based on the number of concussions they sustained during their NFL career. The retired players will then be assessed utilizing pituitary hormonal blood tests, body composition testing and neurobehavioral, quality of life and sexual function surveys. Retirees found to be deficient in any hormones such as thyroid, testosterone or growth hormone will be treated with physiological replacement doses of the appropriate hormone and will then have repeat quality of life testing. Hormonal testing assays will be conducted by the General Clinical Research Center at Harbor-UCLA Medical Center under the direction of Professor Christina Wang, an endocrinologist and a study co-investigator.

"The problem of sports-related concussions is increasingly recognized as a major contributor to long-term disability in many retired athletes," said Bob Klein, vice president at Saint John's Health Center and a ten-year NFL veteran with the Los Angeles Rams and San Diego Chargers. "However, the potential impact of concussions on quality of life is not well understood. This research will fill that gap in our knowledge. I have spoken with many of my former colleagues in the NFL, and they share my belief in the critical importance of this study."

The Neuro-Endocrine Tumor Center (www.neuro-endo.org) is housed at Saint John's Health Center and the John Wayne Cancer Institute in Santa Monica, California. The Center's focus of activities is the treatment of pituitary tumors, brain tumors, and other neuro-endocrine disorders including pituitary hormonal deficiencies.

The Center for the Study of Retired Athletes at the University of North Carolina works in close affiliation with the National Football League Players Association. Since 2001, the Center has been investigating a spectrum of physical and mental disabilities common to retired athletes. The research team will begin work in July 2008, with initial research results expected in 2010.

Since its founding in 1942 by the Sisters of Charity of Leavenworth, Saint John's Health Center has been providing the patients and families of Santa Monica, West Los Angeles and ocean communities with compassionate, advanced medical care. Saint John's provides a spectrum of treatment and diagnostic services with distinguished areas of excellence in cancer care, cardiac care, orthopedics and women's health. Saint John's Health Center is also dedicated to bringing to the community the most innovative advances in technology and patient care available in a healing environment.

Since 1981, the John Wayne name has been committed by the Wayne family to groundbreaking cancer research in memory of the much-loved actor who died of cancer. The John Wayne Cancer Institute has received worldwide acclaim for advances in understanding the disease, focusing on melanoma (skin cancer), breast, prostate, colon, pancreatic, lung and liver cancer, as well as lymphoma and leukemia. With its unique ability to rapidly turn scientific breakthroughs into innovative approaches to treatment and early detection, JWCI provides immediate hope to cancer patients from around the globe.
Contacts

Saint John's Health Center
Greg Harrison, 310/829-8010
858/472-5560 (cell)
gregory.harrison@stjohns.org

Mesothelioma Survival Rates Among Patients Taking New Treatment

noreply@blogger.com (Thuenthkin Anbelos) — Tue, 26 Aug 2008 03:33:00 +0000

LegalView Recounts the Results of a Recent Mesothelioma Study That Reported High Survival Rates Among Patients Taking New Treatment

LegalView reported the results of an Italian study to its mesothelioma blog readers; the results detailed a positive outcome and increased survival rate for elderly pleural mesothelioma victims. The study, recently published in a British medical journal, used a combination of two medicinal treatments commonly prescribed separately.

Denver, CO, August 16, 2008 -- LegalView, the most comprehensive legal resource available on the Web, recounted the results of an Italian study to its mesothelioma information blog readers. The study attempted to increase the survival rate of elderly pleural mesothelioma patients by combining two medications: Alimta (pemtrexed) and Paraplatin (carboplatin). The results of the study were released in a June issue of the British Journal of Cancer and the conclusions detailed the highly-effective treatments, which increased the survival rate among pleural mesothelioma patients 65 years of age or older.

Mesothelioma is an incurable cancer that is often attributed to the inhalation of asbestos fibers and dust containing tremolite. Asbestos is a known carcinogen, according to the Environmental Protection Agency (EPA), which is responsible for regulating the cleanup of the hazardous material. Asbestos was often prized for its ability to remain fire-resistant, while being produced cheaply, and served as a key ingredient in many products including insulation that was implemented into homes, apartment complexes, universities, schools, business offices and hospitals around the country. Individuals who suffer from mesothelioma cancer are advised to speak with a knowledgeable mesothelioma attorney in order to better educate themselves on the possibility for developing a mesothelioma lawsuit. Due to the extremely costly medical bills associated with increasing survival rate among mesothelioma cancer victims, developing litigation may result in monetary compensation to assist with those medical bills.

LegalView not only offers resources on the most recent mesothelioma news and clinical trials, but also offers information on a variety of other legal issues afflicting millions of Americans. Most recently, LegalView updated several of its pharmaceutical drug information portals with news on updates and recalls; some of the portals include Viapro, Ketek and the Zimmer Durom cup.

The development of the Viapro information portal occurred after the U.S. Food and Drug Administration (FDA) issued a press release on the recall of the drug because of contamination of a harmful chemical known as thiomethisosildenafil. The male sexual-enhancement prescription drug, manufactured by EG Labs, is used to treat erectile dysfunction (ED). The undeclared ingredient may be harmful to patients especially when interacting with nitrates found in other prescription drugs. The Viapro recall occurred because the drug may cause dangerously low levels of blood pressure among patients also taking nitroglycerin for diabetes, high blood pressure, high cholesterol or heart disease.

Ketek, which is an antibiotic used to treat upper respiratory infections such as pneumonia, bronchitis and sinusitis, had its warning labels increased recently due to the threat of liver disease among patients consuming the drug. To learn more about the Ketek side effects, visit http://ketek.legalview.com/.

Also among the recently updated information portals is that of the Zimmer Durom cup. Zimmer Holdings has ceased production of its Durom cup because of complaints that the hip socket was failing among many patients. Although the company has ceased production of the hip socket, pending internal investigations into the potential failure, the hip socket has already been used in over 12,000 hip replacement procedures since its introduction to the market in 2006. Patients who may be at risk for the Durom cup failure should seek medical attention immediately to ensure no further damage occurs.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com
www.legalview.com

Industry Makes Request to Decrease Asbestos Regulations

noreply@blogger.com (Thuenthkin Anbelos) — Tue, 19 Aug 2008 15:30:00 +0000

LegalView Offers Mesothelioma Blog Readers Details of Disconcerting Request to Decrease Asbestos Regulations from Industry

LegalView informed mesothelioma blog readers of an potentially troubling request by automotive, chemical and mining industries' paid researchers to "water down" asbestos regulations. The industry-hired scientists argued that asbestos is no longer as dangerous, even though several international health organizations have declared no safe level of the material.

Denver, CO - August 2, 2008 -- LegalView, the number one resource for everything and anything legal on the Internet, recently updated readers with the latest piece of mesothelioma information, relating to the request by paid researchers for the automotive, chemical and mining industries to decrease asbestos regulations. In a July 2008 summit in Washington D.C., the Environmental Protection Agency (EPA) met with the Office of Solid Waste and Emergency regarding the request. The industry researchers argued that asbestos fibers found in sand, taconite and other materials are less toxic than originally deemed in the 1980s when the regulations were created. However, the EPA along with the International Agency for Research on Cancer, the Occupational Safety and Health Administration (OSHA) and The World Health Organization (WHO) have all determined that no level of exposure to asbestos fibers is safe and the material as well as products using asbestos should be permanently banned.

Asbestos was mined for years and was frequently used in the construction industry for an array of products, most often insulation. However, it was determined that exposure to asbestos fibers causes a deadly form of lung cancer known as mesothelioma. Individuals who suffer from mesothelioma cancer should contact an experienced mesothelioma attorney to receive a legal consultation on the possibility of developing a personalized mesothelioma lawsuit. Because the cancer is fatal and no completely effective mesothelioma treatment exists to reduce the disease it may be important to develop litigation and potentially receive monetary compensation to pay for costly medical bills. Mesothelioma is a dormant condition that can take decades before symptoms reveal themselves, at which point, little can be done to improve the illness.

According to news reports, at the Washington D.C. summit, approximately 83 public health officials signed a 29-page report on the "science-for-hire" practice, which Dr. Michael Silverstein, who wrote the report, alleges is occurring on the part of automotive, chemical and mining industries. The report, opposing the request, urged the EPA to focus on public health rather than big industry and to avoid decreasing the asbestos regulations.

Learn more about this ongoing issue as well as other legal issues through LegalView.com. LegalView continues to maintain a comprehensive library of legal issues; issues that may be causing harm to millions of Americans each year. LegalView recently updated several of its issues to include detailed information and news. Some of the recently updated sites include information on the Zimmer Durom cup, the Ketek antibiotic and Avandia prescriptions.

The Durom cup, manufactured by Zimmer Holdings, is an artificial hip component that has been under fire by physicians who have said the device is failing their patients. Because of the alleged Zimmer Durom cup risks, the company has ceased manufacture of the hip socket. However, since production began in 2006, nearly 12,000 patients received the cup and may be affected by the failing hip socket and should contact a knowledgeable attorney for advice about the potential Durom cup recall.

Ketek is a pharmaceutical prescription antibiotic that is used to treat upper respiratory infections including pneumonia or bronchitis. Reports have tied the antibiotic with the possibility of severe liver damage among patients. Additional Ketek side effects may also be considered dangerous and those who report signs of yellowing skin or jaundice should consult a doctor immediately

The Avandia portal is continually being updated to provide the public with extensive research, scientific findings and experienced attorney links. Avandia is a prescription drug used to treat type 2 diabetes, which currently affects millions of individuals in the United States. Recent research, however, has found a disturbing link between the use of Avandia and an increase of heart disease as well as osteoporosis among patients. Individuals who feel they may have symptoms relating to heart disease or who have suffered from a bone fracture likely induced by the Avandia side effects, should speak with a medical expert immediately. Additionally, it is advisable to locate an experienced pharmaceutical law firm in case legal advice is necessary for an Avandia settlement.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

CONTACT INFORMATION
Katie Kelley
LegalView
720-226-6613

Alan Haburchak
LegalView
720-226-6613

Revolutionary HIV Testing Bill Passes

noreply@blogger.com (Thuenthkin Anbelos) — Wed, 13 Aug 2008 04:24:00 +0000

Bill to 'Revolutionize' HIV Testing Passes California Legislature Unanimously

AB 2899 (Portantino, D-Pasadena), Sponsored by AIDS Healthcare Foundation (AHF), Overhauls Counseling Model for HIV Testing Programs; Bill Eliminates Outdated 'One Size Fits All' Approach for More Prudent Public Health Approach

SACRAMENTO, Calif.-- August 12, 2008 --AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised the California Legislature for its passage this week of Assembly Bill 2899 (Portantino, D-Pasadena).

"AB 2899 will revolutionize the way we do HIV testing in California, and we strongly urge the Governor to sign this bill," said Michael Weinstein, President of AIDS Healthcare Foundation. "Today, in government-funded programs, extensive education and counseling is required for every person regardless of how many times they might have been tested. Treating the young person, who is testing for the first time the same as a person in their forties or fifties who has been tested dozens of times doesn't make sense. This important reform will allow AHF, the largest HIV tester in California, to do three times as many tests per hour as we do now. The unanimous approval of the legislature for this common sense approach to HIV testing is very encouraging."

The bill, known as the Sexually Transmitted Diseases and HIV/AIDS Counseling Reform Bill, unanimously cleared both chambers of the Legislature this week-clearing the California Assembly (64-0) earlier today after clearing the Senate in a 36 to 0 vote yesterday.

"This bill brings the requirements for HIV counseling in line with where we are today in our knowledge and understanding of HIV/AIDS and other STDs, and it will allow us to focus our counseling efforts where they are most needed-to those at high risk and those who may test positive," said Joey Terrill, Acting Director of Public Affairs for AIDS Healthcare Foundation, co-sponsor of the bill. "The California Legislature has recognized the importance of this prudent public health legislation with its unanimous passage in both chambers. When this bill is chaptered into law, it will allow the Department of Public Health and the State Office of AIDS far more flexibility in its counseling regulations to best serve and reflect the needs of communities throughout California."

AB 2899 codifies the changes that testing organizations need to conform their practices to current needs and to facilitate the swift introduction of newer counseling models by the Office of AIDS.

About AHF

AIDS Healthcare Foundation (AHF) is the nation's largest non-profit HIV/AIDS healthcare provider. AHF currently provides medical care and/or services to more than 80,000 individuals in 20 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at www.aidshealth.org
Contacts

AIDS Healthcare Foundation
Ged Kenslea, 323-860-5225
Mobile: 323-791-5523
gedk@aidshealth.org
or
Lori Yeghiayan, 323-860-5227
Mobile: 323-377-4312
lori.yeghiayan@aidshealth.org

Families Informed About Insurance Coverage With Medical Reimbursement Resource

noreply@blogger.com (Thuenthkin Anbelos) — Thu, 07 Aug 2008 19:52:00 +0000

Medical Reimbursement Resource LLC of Houston Helps Families Stay Informed, Choose Right Insurance Coverage

Company Educates Consumers of Medicare Part C Advantage Plan Enrollment Period Deadline - March 31, 2008

Houston, TX - March 12 -- Medical Reimbursement Resource (MRR) LLC, a leading patient advocacy company in Houston, advises the Medicare community of March 31st Medicare Part C enrollment deadline and helps educate consumers on the best health insurance choices for their situation.

MRR professionals explain that the Medicare program is a federal program that helps senior citizens and other qualifying individuals pay for health care. Divided into parts, A, B, C, and D, Part C is an alternative to Parts A and B. Under Part C, private health insurance companies can contract with the federal government to offer Medicare benefits through their own policies.

"Medicare Part C Advantage Plans are not for everyone. Generally the choice of providers is more limited than with traditional Medicare Parts A & B. Individuals with special health problems and working with physicians that are important to them are recommended to remain on Medicare Parts A and B," said MRR owner Jane Lehto.

"However, it's great to have another insurance option available for Medicare beneficiaries. This is where Medicare Part C comes in," Lehto added.

Lehto and her staff help clients choose the right insurance coverage and receive all benefits to which they are entitled under their particular policy. With over 40 plans from which to choose in Texas, it is an often difficult process through which to navigate for the unknowing consumer.

Lehto further explained that the type of candidates qualifying for the Medicare Part C, particularly the Medicare Part C Advantage Plus plan, would be those in fragile health and on fixed incomes. The relatively new plans include either HMO's or PPO's and come with modest premiums. A vast number of physicians and hospitals participate in the plans.

"And effective this past January is the option for those switching from Medicare Parts A and B to return to their plans for whatever reason during the enrollment period from November 15 through December 31, 2008," said Lehto.

MRR also assists patients and their families with problem health insurance claims and medical bills, benefit issues, along with insurance choices and a myriad of issues that the consumer faces in today's challenging and complex insurance world. To learn more about Medical Reimbursement Resource LLC, call 1-713-526-0955 or log onto www.mrrmedical.com today.

Press Contact: Philip O'Hara
Company Name: Medical Reimbursement Resource LLC
Texas Phone: 713-526-0955
Website: www.mrrmedical.com

Predicted Increase in Female Mesothelioma Victims

noreply@blogger.com (Thuenthkin Anbelos) — Thu, 07 Aug 2008 04:34:00 +0000

LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims

LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause.

Denver, CO - July 21, 2008 -- LegalView, the most comprehensive legal resource on the Web, reported on its mesothelioma information blog a potential increase of mesothelioma cancer victims within the next few years, particularly among women, according to researchers. In 1979, the U.S. Consumer Product Safety Commission (CPSC) released information regarding 26 companies and manufacturers of hand-held hair dryers that had been made with asbestos. While the 26 companies had voluntarily taken action to correct the asbestos-containing hair dryers, individuals who had used the tainted hair dryers may be at risk for developing mesothelioma and should consider contacting a mesothelioma lawyer for information on the development of a potential mesothelioma lawsuit.

Mesothelioma is a deadly form of lung cancer that is caused through the inhalation of asbestos fibers. While asbestos was largely used in the construction industry, commonly within insulation, it has also been used in other products including hair dryers. While the hair dryers were corrected and became asbestos-free nearly 30 years ago it is common for mesothelioma to remain dormant for years and even decades, which is why researchers are concerned with a new group of individuals becoming afflicted by mesothelioma and symptoms becoming prevalent now. Researchers are also particularly concerned for women because women allegedly use hair dryers more than men. To learn more about developing litigation, contact a mesothelioma law firm or mesothelioma attorney to better understand the potential for developing an asbestos-related lawsuit and receiving monetary compensation for the costly bills usually associated with a mesothelioma cancer diagnosis.

In addition to information on mesothelioma, LegalView also offers details on a plethora of other legal issues afflicting millions of Americans each year. For example, readers can learn about the latest fluoroquinolones black box warning labeling. Fluoroquinolones are a group of antibiotics that have become increasingly at risk for severe side effects. Of the fluoroquinolones group, the most commonly prescribed drugs are Levaquin and Cipro. Levaquin, also known as levofloxacin, is manufactured by Ortho-McNeil and treats bacterial infections, specifically treating infections such as skin infections, chronic bacterial prostates, urinary tract infections, pneumonia, bronchitis and acute pyelonephritis caused by Escherichia coli (E. coli). The drug, which was released in 1996, has been the center of numerous clinical trials and studies because of the possible Levaquin side effects, which can include the most serious - Achilles tendon rupture - as well as jaundice, seizures, hallucinations, abdominal tenderness and limb numbness.

Similar to Levaquin is Cipro (ciprofloxacin) from Bayer A.G., which was approved for market use in 2000 and is used to treat bacterial infections similar to those treated by Levaquin. The Cipro risks are the same as Levaquin, which is an increased risk of tendonitis. Additionally, Cipro has other side effects that may also be harmful to patients. Some of the side effects include seizure, difficulty breathing, depression, suicidal thoughts, blacking out and hallucinations.

LegalView also has information on other controversial prescription drugs including Avandia. Avandia is a type 2 diabetes drug that has recently been linked to severe risks among patients. The Avandia dangers may include an increased risk of heart failure as well as a higher risk of developing early onset osteoporosis. Patients who may have developed either of these side effects while taking Avandia should speak with an experienced pharmaceutical lawyer to better understand the potential for developing a potential Avandia lawsuit.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Foundation Funds Follow-up Care in Revolutionary Cancer Vaccine Study

noreply@blogger.com (Thuenthkin Anbelos) — Sun, 27 Jul 2008 17:51:00 +0000

Onyx and Breezy Foundation Funds Follow-up Care in Revolutionary Cancer Vaccine Study

The Onyx & Breezy Foundation recently funded after-care for dogs engaged in a revolutionary research study to develop a cancer vaccine that may be given to both humans and animals when successful. The study is being conducted at The Matthew J. Ryan Veterinary Hospital, a small animal teaching hospital affiliated with the University of Pennsylvania in Philadelphia.

Tuxedo Park, NY and Philadelphia, PA - March 14 -- The Onyx & Breezy Foundation has announced a gift to The University of Pennsylvania School of Veterinary Medicine. The gift will cover the expense of follow-up care for 12 dogs that are currently enrolled in the School's cancer vaccine study.

"Thanks to this generous gift, more participants in our lymphoma cancer vaccine clinical trial will be able to return for follow-up care," said Dr. Karin Sorenmo, chief of oncology at the Matthew J. Ryan Veterinary Hospital. "This means that we can capture all the data that is needed for the study while pet owners are helped financially."

Prior gifts to The Matthew J. Ryan Veterinary Hospital from the Foundation have been a respirator for their ICU department and a mast cell tumor research study.

Dr. Sorenmo treated Breezy, who had mast cell tumors. "Thanks to Dr. Sorenmo, Breezy lived another 2 years, of quality life, after other vets gave her only 6 weeks to live," said Wanda Shefts. "We are glad that this project will help owners of dogs in remission from lymphoma and help advance Dr. Sorenmo's work on the cancer vaccine.

Dr. Sorenmo stated that she was encouraged by the results and she is hoping that this is just the beginning of more trials that can benefit dogs and ultimately help people. Thanks to this study, a number of the participating dogs are now cancer free. The researchers now estimate that they are within two years of testing the vaccine on humans. Without the dogs, they would be more than a decade away.

"We have a tremendous amount of respect for the work they do at the Hospital and we are glad to be able to fund another project for them", said Mark Shefts.

For more information about Penn Vet, please visit www.vet.upenn.edu; for more information about The Onyx and Breezy Foundation, please visit www.onyxandbreezy.org.

The Onyx and Breezy Foundation Background

The Foundation was created in 2004 and named after the trustees Mark & Wanda Shefts' two Labrador Retrievers. The Foundation lends financial support to organizations that benefit the welfare of animals.

The University Of Pennsylvania School Of Veterinary Medicine Background

Penn's School of Veterinary Medicine is one of the world's premier veterinary schools. Founded in 1884, the School was built on the concept of Many Species, One MedicineTM. The birthplace of veterinary specialties, the School serves a distinctly diverse array of animal patients, from pets to horses to farm animals.

Press Contact: Barbara Kauffman
Company Name: The Onyx & Breezy Foundation
Phone: 201-782-7400
Website: www.onyxandbreezy.org

Baxter Heparin Information on Additional Heparin Recall

noreply@blogger.com (Thuenthkin Anbelos) — Wed, 09 Jul 2008 15:32:00 +0000

LegalView Expands Baxter Heparin Information Portal to Include Information on an Additional Heparin Recall

LegalView updated its Baxter Heparin information portal to add information on the most recent recall of the blood-thinning drug. Heparin, which is used to control blood during surgical procedures, was recently discovered to have a Heparin-like contaminant that sickened many and caused at least 19 deaths.

Denver, CO - March 31, 2008 -- The Baxter Heparin practice area on LegalView's site, the source for everything legal on the Web, was recently expanded to explain details of an additional Heparin recall . Heparin has been linked to hundreds of allergic reactions among patients as well as having been connected with 19 deaths. B. Braun Medical Inc. issued the most recent recall of Heparin, which was supplied from Scientific Protein Laboratories - the same company that supplied Baxter Healthcare Corporation with the contaminated Baxter Heparin. According to the U.S. Food and Drug Administration (FDA) and B. Braun Medical Inc., no one was reportedly sickened off of the Heparin from B. Braun Medical but it did have a "heparin-like contaminant," which was enough for the company to recall the drug.

Heparin is blood-thinner injected into patients who are undergoing surgical procedures such as heart disease or kidney dialysis. It is a drug that has been imported to the United States since the 1930s and is derived from pig intestines. Many surgeons find that Heparin is an extremely important drug because it prevents blood clots from forming during surgery, which can result in death among patients. However, earlier this year, a rash of individuals who had been given Heparin during a surgical procedure had allergic reactions. Individuals who have been affected by the contaminated Heparin should consider contacting a Heparin lawyer to learn about developing a Heparin class action lawsuit for which compensation may be derived from manufacturers if the tainted drug.

The Baxter Heparin that was initially recalled had been tainted with a chemical known as over-sulfated chondroitin sulfate. Through an FDA investigation, it was discovered that a Chinese company that produces the drug was responsible for the tainted Heparin. Although an investigation continues to be ongoing as to whether the chemical was intentionally or accidentally introduced into a batch of the Heparin. According to news reports, using the over-sulfated chondroitin sulfate allows for a reduction in the production of production for Heparin.

For information on additionally recalled prescription drugs or to report an adverse reaction to a prescribed drug, visit LegalView's many unsafe drugs information portals. Here, readers will find information on recently recalled drugs as well as prescription drugs under investigation such as Chantix, Avandia and Trasylol Aprotinin.

Chantix is a smoking cessation drug from Pfizer that was first introduced to the market, with FDA approval, in mid-2006. However, in late-2007 the FDA began an investigation into nearly 400 reports of suicidal tendencies and behaviors among patients. Additionally, nearly 37 suicides have been associated with the Chantix side effects, which include psychotic episodes, depression, suicidal thoughts and erratic behavior.

Avandia is a prescription drug used to treat diabetes 2 among patients; however, the drug has been linked to several serious side effects including an increased risk of heart disease and a higher chance of early onset osteoporosis. Individuals who are taking Avandia are advised to locate an experienced pharmaceutical law firm to receive consultation on an Avandia lawsuit.

Trasylol, also known as its generic version Aprotinin, is similar to Heparin in that it is used during surgical procedures to control blood loss. A study was released in 2006 from the New England Journal of Medicine, which found that the use of Trasylol Aprotinin increased the chances of a patient developing heart disease, kidney disease, stroke and death. Patients who received or may have received Trasylol or it's generic version should use LegalView's information portal to find an Trasylol attorney.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://baxter-heparin.legalview.com

Eating Between The Lines

noreply@blogger.com (Thuenthkin Anbelos) — Wed, 09 Jul 2008 01:34:00 +0000

A Health Diary and Food Journal for the Rest of Us

For women who would like to keep a food diary, exercise log and health journal in two minutes a day or less. The Bio-Diary for Women by FitMinder is an easy-to-use alternative to food and exercise journals that require tedious daily entries. Its unique format offers and useful and beautiful tool to record and analyze health information.

Sacramento, CA, June 25, 2008 -- Keeping a food diary or health journal is highly recommended these days as a way to manage diet and health. But many people are put off by the thought of recording every bite they eat. They are too busy living their lives to spend the day recording it. Now there's an alternative for people who want to track diet, exercise, and health issues, without the tedious detail.

Most food journals and exercise logs are designed for people who are committed to detailed daily tracking of their progress. But what about people who can't commit to that level, but still want the usefulness of a food diary, exercise log, and health journal -- for things like illnesses, medications, sleep problems, allergies, stress, energy level and other health issues? And what if the most time they could commit was a couple of minutes, once a day?

Marie Karner, a Sacramento business owner, has been keeping a health journal for six years, and has designed a simple and effective tool for women who only have time for the big picture. For those whose life speedometer runs in weeks or months -- not hours or days, the Bio-Diary's "quick-scan" format helps manage health info and keep goals in sight.

The Bio-Diary for WomenT uses a simple monthly log book format with columns, and tracks one month at a time, using eight different pages. Two minutes is about all it takes to jot down one day's worth of meals, exercise, health symptoms and other info. The format is flexible and can be customized to suit different needs. Because it provides a snapshot view of months at a glance, it is particularly useful in identifying cause-and-effect relationships, and analyzing patterns and trends. Each month features a diary page for moments when a minute or two of writing is not only therapeutic, but useful as well.

The Bio-Diary for WomenT is available online at Amazon and also at FitMinder Publishing's website at fitminder.com.

Contact Information
FitMinder Publishing
Marie Karner
916-635-0511
mariek@fitminder.com
www.fitminder.com